Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

28
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

40
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

27
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

132
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
132

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise performance in patients with heart failure and impaired iron transport: a single-centre retrospective study.

BMJ open·2026
Same author

Predicting subclinical atherosclerosis in adults with type 1 diabetes using cardiovascular risk models: a cross‑sectional study from Italy.

Cardiovascular diabetology·2026
Same author

Prognostic Impact of Cancer in Patients Hospitalized for Acute Myocardial Infarction: A Population-Based Cohort Study.

Journal of clinical medicine·2026
Same author

Circulating cytokines as triggers of endothelial dysfunction and sex-specific interstitial cell response in fibrocalcific aortic valve disease.

International journal of biological sciences·2026
Same author

Gastrointestinal complications after cardiac surgery: a retrospective case-control study and risk score development.

Frontiers in cardiovascular medicine·2026
Same author

Advanced CCTA imaging, angiography-based Radial Wall strain and μFR versus IVUS-NIRS to enhance identification of lipid-rich vulnerable plaques: A multimodality imaging approach.

Progress in cardiovascular diseases·2026

Related Experiment Video

Updated: Sep 2, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

204

Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI

Ugo Corrà1, Massimo Francesco Piepoli2, Andrea Giordano3

  • 1Division of Rehabilitation Cardiology, Istituti Clinici Scientifici, IRCCS, Istituto di Veruno, Gattico-Veruno, Italy.

The American Journal of Cardiology
|August 1, 2022
PubMed
Summary

Cardiopulmonary exercise testing accurately predicts cardiovascular events in heart failure with reduced ejection fraction (HFrEF). The validated algorithm uses peak oxygen consumption and ventilatory responses, proving effective for guiding treatment decisions.

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

Related Experiment Videos

Last Updated: Sep 2, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

204
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Cardiopulmonary exercise testing (CPET) is crucial for prognostication in heart failure with reduced left ventricular ejection fraction (HFrEF).
  • Existing prognostic algorithms require validation in diverse patient cohorts.

Purpose of the Study:

  • To validate a prognostic algorithm for HFrEF patients using CPET parameters.
  • To assess the algorithm's performance in predicting cardiovascular events (CV).

Main Methods:

  • Utilized the metabolic exercise test data combined with cardiac and kidney indexes (MECKIs) database, enrolling 4,683 HFrEF patients.
  • Analyzed peak oxygen consumption (VO2), VE/VCO2 slope, exertional oscillatory ventilation (EOV), and peak respiratory exchange ratio.
  • Evaluated 3-year cardiovascular death and urgent heart transplantation rates.

Main Results:

  • The algorithm was validated in the MECKI cohort, confirming its prognostic utility.
  • Patients on beta-blockers showed significantly lower CV events (11%) compared to those not on beta-blockers (25%).
  • Specific CPET parameters (peak VO2, VE/VCO2 slope, peak respiratory exchange ratio, EOV) effectively stratified risk in both treatment groups.

Conclusions:

  • The validated algorithm accurately predicts cardiovascular events in HFrEF patients.
  • CPET parameters are essential for risk stratification and guiding treatment strategies in HFrEF.
  • Beta-blocker therapy is associated with improved outcomes in HFrEF patients.